Group 1 - The core announcement is that Meizhong Jiahe plans to raise approximately HKD 270 million through the placement of 48,723,600 new H shares, with a net amount of about HKD 260 million after expenses [1] - The placement price is set at HKD 5.54 per share, representing a discount of approximately 16.9% to the closing price of HKD 6.67 on July 21, 2025, and a discount of about 19.9% to the average closing price of HKD 6.92 over the previous five trading days [1] - The newly issued shares will account for approximately 6.6% of the existing issued share capital and about 6.2% of the enlarged share capital after the placement [1] Group 2 - The funds raised will be allocated for the construction of Shanghai Taihe Cheng Cancer Hospital, support for medical AI business needs, repayment of financial institution loans, and to supplement working capital [1] - The issuance is conducted under a general mandate granted by the shareholders' meeting and is expected to be completed on the second business day after obtaining listing approval, no later than July 29, 2025 [1]
美中嘉和 ：通过一般授权配售新 H 股募资约 2.7 亿港元 改善资本结构及储备资金